Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

[Comparison of local immune microenvironment between liver-metastasis colorectal cancer and non-liver-metastasis colorectal cancer].

Zou YF, Cai ZR, Chen YF, Rong YM, Wu XR, Yuan RX, He XS, Wu XJ, Lan P.

Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Jun;16(6):547-51. Chinese.

PMID:
23801208
2.

Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.

Hu H, Sun L, Guo C, Liu Q, Zhou Z, Peng L, Pan J, Yu L, Lou J, Yang Z, Zhao P, Ran Y.

Clin Cancer Res. 2009 Sep 1;15(17):5485-93. doi: 10.1158/1078-0432.CCR-08-2491. Epub 2009 Aug 25.

3.

Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases.

Gulubova M, Manolova I, Kyurkchiev D, Julianov A, Altunkova I.

APMIS. 2009 Dec;117(12):870-9. doi: 10.1111/j.1600-0463.2009.02547.x.

PMID:
20078551
4.

Fas ligand expression is a risk factor for liver metastasis in colorectal cancer with venous invasion.

Yokomizo H, Yoshimatsu K, Ishibashi K, Hashimoto M, Yosida K, Kato H, Naritaka Y, Okada Y, Ogawa K.

Anticancer Res. 2003 Nov-Dec;23(6D):5221-4.

PMID:
14981993
5.

Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.

Wang LG, Gu J.

Cancer Epidemiol. 2012 Feb;36(1):e61-7. doi: 10.1016/j.canep.2011.05.002. Epub 2011 Oct 21.

PMID:
22018950
6.

Relationship of TGF-β1 and Smad7 expression with decreased dendritic cell infiltration in liver gastrointestinal cancer metastasis.

Gulubova M, Manolova I, Ananiev J, Kjurkchiev D, Julianov A, Altunkova I.

APMIS. 2013 Oct;121(10):967-75. doi: 10.1111/apm.12096. Epub 2013 Sep 2.

PMID:
23998914
7.

The relationship between prognosis and CEA-dt after hepatic resection in patients with colorectal carcinomas.

Koga H, Moriya Y, Akasu T, Fujita S.

Eur J Surg Oncol. 1999 Jun;25(3):292-6.

PMID:
10336810
8.

Significance of proliferating cell nuclear antigen expression in liver metastasis of colorectal cancer.

Liao G, Zhang Y, Shen M, Jiang H, Yan Z.

Dis Colon Rectum. 1997 Dec;40(12):1489-93.

PMID:
9407990
9.

Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges?

Chiu CT, Chiang JM, Yeh TS, Tseng JH, Chen TC, Jan YY, Chen MF.

Dig Liver Dis. 2008 Sep;40(9):749-54. doi: 10.1016/j.dld.2008.01.018. Epub 2008 Mar 10.

PMID:
18329969
10.

Combination of haptoglobin and osteopontin could predict colorectal cancer hepatic metastasis.

Sun L, Pan J, Peng L, Fang L, Zhao X, Sun L, Yang Z, Ran Y.

Ann Surg Oncol. 2012 Jul;19(7):2411-9. doi: 10.1245/s10434-011-2177-2. Epub 2012 Jan 5.

PMID:
22219064
11.

A comparative study of protein expression in primary colorectal cancer and synchronous hepatic metastases: the significance of matrix metalloproteinase-1 expression as a predictor of liver metastasis.

Kim YW, Ko YT, Kim NK, Chung HC, Min BS, Lee KY, Park JP, Kim H.

Scand J Gastroenterol. 2010;45(2):217-25. doi: 10.3109/00365520903453158.

PMID:
20095886
12.

Immunohistochemical study of colorectal cancer liver metastases: the immune/inflammatory infiltrate.

Giuşcă SE, Zugun FE, Târcoveanu E, Carasevici E, Amălinei C, Căruntu ID.

Rom J Morphol Embryol. 2010;51(1):73-9.

13.

Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.

Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S, Osada S, Ichikawa Y, Shimada H.

Ann Surg Oncol. 2008 Dec;15(12):3433-9. doi: 10.1245/s10434-008-0168-8. Epub 2008 Oct 10.

PMID:
18846401
14.

Characteristic differences between patients who have undergone surgical treatment for lung metastasis or hepatic metastasis from colorectal cancer.

Iwasaki A, Shirakusa T, Yamashita Y, Noritomi T, Maekawa T, Hamada T.

Thorac Cardiovasc Surg. 2005 Dec;53(6):358-64.

PMID:
16311973
15.

Regulatory T-cell-mediated inhibition of antitumor immune responses is associated with clinical outcome in patients with liver metastasis from colorectal cancer.

Brudvik KW, Henjum K, Aandahl EM, Bjørnbeth BA, Taskén K.

Cancer Immunol Immunother. 2012 Jul;61(7):1045-53. doi: 10.1007/s00262-011-1174-4. Epub 2011 Dec 11.

PMID:
22159472
16.

[Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].

Aldrighetti L, Castoldi R, Di Palo S, Arru M, Stella M, Orsenigo E, Gavazzi F, Ferla G, Di Carlo V, Staudacher C.

Chir Ital. 2005 Sep-Oct;57(5):555-70. Italian.

PMID:
16241086
17.

Cancer/testis antigens and clinical risk factors for liver metastasis of colorectal cancer: a predictive panel.

Chen Z, Li M, Yuan Y, Wang Q, Yan L, Gu J.

Dis Colon Rectum. 2010 Jan;53(1):31-8. doi: 10.1007/DCR.0b013e3181bdca3a.

PMID:
20010347
18.

Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?

Bakalakos EA, Burak WE Jr, Young DC, Martin EW Jr.

Am J Surg. 1999 Jan;177(1):2-6.

PMID:
10037299
19.
20.

Activation of tumor-specific T lymphocytes after laser-induced thermotherapy in patients with colorectal liver metastases.

Vogl TJ, Wissniowski TT, Naguib NN, Hammerstingl RM, Mack MG, Münch S, Ocker M, Strobel D, Hahn EG, Hänsler J.

Cancer Immunol Immunother. 2009 Oct;58(10):1557-63. doi: 10.1007/s00262-009-0663-1. Epub 2009 Jan 29.

PMID:
19184001

Supplemental Content

Support Center